Archives of Neuroscience

Published by: Kowsar
Uncorrected Proof scheduled for 6 (2)

Epidemiological Features of Ischemic Brain Stroke; a Cross-Sectional Hospital-Based Study

Anita Sabzghabaei 1 , Sohrab Aeinechian 1 , Majid Shojaee 1 , Parvin Kashani 1 and Mohammad Manouchehrifar 1 , *
Authors Information
1 Department of Emergency Medicine, Shahid Beheshti Medical University, Tehran, Iran
Article information
  • Archives of Neuroscience: In Press (In Press); e74362
  • Published Online: April 13, 2019
  • Article Type: Research Article
  • Received: May 6, 2018
  • Revised: December 6, 2018
  • Accepted: December 19, 2018
  • DOI: 10.5812/ans.74362

To Cite: Sabzghabaei A , Aeinechian S , Shojaee M, Kashani P, Manouchehrifar M. Epidemiological Features of Ischemic Brain Stroke; a Cross-Sectional Hospital-Based Study, Arch Neurosci. Online ahead of Print ; In Press(In Press):e74362. doi: 10.5812/ans.74362.

Abstract
Copyright © 2019, Archives of Neuroscience. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Methods
4. Results
5. Discussion
Footnotes
References
  • 1. Goldstein LB, Adams R, Becker K, Furberg CD, Gorelick PB, Hademenos G, et al. Primary prevention of ischemic stroke: A statement for healthcare professionals from the Stroke Council of the American Heart Association. Stroke. 2001;32(1):280-99. doi: 10.1161/01.STR.32.1.280. [PubMed: 11136952].
  • 2. Roth EJ, Lovell L, Harvey RL, Heinemann AW, Semik P, Diaz S. Incidence of and risk factors for medical complications during stroke rehabilitation. Stroke. 2001;32(2):523-9. doi: 10.1161/01.STR.32.2.523. [PubMed: 11157192].
  • 3. Delavar Kasmaei H, Baratloo A, Nasiri Z, Soleymani M, Oraee Yazdani M. Recombinant tissue plasminogen activator administration in patients with cerebrovascular accident; a case series. Arch Neurosci. 2015;2(3). e23315. doi: 10.5812/archneurosci.23315.
  • 4. Taheraghdam AA, Sharifipour E, Pashapour A, Namdar S, Hatami A, Houshmandzad S, et al. Allopurinol as a preventive contrivance after acute ischemic stroke in patients with a high level of serum uric acid: A randomized, controlled trial. Med Princ Pract. 2014;23(2):134-9. doi: 10.1159/000355621. [PubMed: 24296871]. [PubMed Central: PMC5586842].
  • 5. Baratloo A, Rahimpour L, Abushouk AI, Safari S, Lee CW, Abdalvand A. Effects of telestroke on thrombolysis times and outcomes: A meta-analysis. Prehosp Emerg Care. 2018;22(4):472-84. doi: 10.1080/10903127.2017.1408728. [PubMed: 29345529].
  • 6. Kapral MK, Fang J, Hill MD, Silver F, Richards J, Jaigobin C, et al. Sex differences in stroke care and outcomes: Results from the Registry of the Canadian Stroke Network. Stroke. 2005;36(4):809-14. doi: 10.1161/01.STR.0000157662.09551.e5. [PubMed: 15731476].
  • 7. Baratloo A, Forouzanfar MM, Hashemi B, Safari S, Delavar Kasmaei H, Rouhipour A, et al. Tissue plasminogen activator: A literature review. Arch Neurosci. 2016;3(1). e30452. doi: 10.5812/archneurosci.30452.
  • 8. Manouchehrifar M, Lakestani M, Kashani P, Safari S. Sonographic diameter of optic nerve sheath in differentiation of ischemic and hemorrhagic strokes; a diagnostic accuracy study. Am J Emerg Med. 2018;36(11):2064-7. doi: 10.1016/j.ajem.2018.08.041. [PubMed: 30135026].
  • 9. Shaafi S, Sharifipour E, Rahmanifar R, Hejazi S, Andalib S, Nikanfar M, et al. Interleukin-6, a reliable prognostic factor for ischemic stroke. Iran J Neurol. 2014;13(2):70-6. [PubMed: 25295149]. [PubMed Central: PMC4187333].
  • 10. Mangum SA, Kraenow KR, Narducci WA. Identifying at-risk patients through community pharmacy-based hypertension and stroke prevention screening projects. J Am Pharm Assoc (Wash). 2003;43(1):50-5. doi: 10.1331/10865800360467042. [PubMed: 23945804].
  • 11. Holroyd-Leduc JM, Kapral MK, Austin PC, Tu JV. Sex differences and similarities in the management and outcome of stroke patients. Stroke. 2000;31(8):1833-7. doi: 10.1161/01.STR.31.8.1833. [PubMed: 10926943].
  • 12. Glader EL, Stegmayr B, Norrving B, Terent A, Hulter-Asberg K, Wester PO, et al. Sex differences in management and outcome after stroke: A Swedish national perspective. Stroke. 2003;34(8):1970-5. doi: 10.1161/01.STR.0000083534.81284.C5. [PubMed: 12855818].
  • 13. Borhani-Haghighi A, Safari R, Heydari ST, Soleimani F, Sharifian M, Yektaparast Kashkuli S, et al. Hospital mortality associated with stroke in southern Iran. Iran J Med Sci. 2013;38(4):314-20. [PubMed: 24293785]. [PubMed Central: PMC3838983].
  • 14. Baratloo A, Safari S, Rouhipour A, Hashemi B, Rahmati F, Motamedi M, et al. The risk of venous thromboembolism with different generation of oral contraceptives; a systematic review and meta-analysis. Emerg (Tehran). 2014;2(1):1-11. [PubMed: 26495334]. [PubMed Central: PMC4614624].
  • 15. Delavar Kasmaei H, Baratloo A, Nasiri Z, Soleymani M, Shirafkan A, Hamedi ZS. Report of nineteen cerebral vein thrombosis referrals to an emergency departmenta case series and literature review. Arch Neurosci. 2014;2(3). e20552. doi: 10.5812/archneurosci.20552.
  • 16. Ashrafi F, Baratloo A, Nasiri Z, Soleymani M, Asaadi S. Secondary stroke after thrombolytic administration; a case report. Arch Neurosci. 2014;2(2). e17315. doi: 10.5812/archneurosci.17315.
  • 17. Ahangar AA, Ashraf Vaghefi SB, Ramaezani M. Epidemiological evaluation of stroke in Babol, northern Iran (2001-2003). Eur Neurol. 2005;54(2):93-7. doi: 10.1159/000088643. [PubMed: 16195668].
  • 18. Oveisgharan S, Sarrafzadegan N, Shirani S, Hosseini S, Hasanzadeh P, Khosravi A. Stroke in Isfahan, Iran: Hospital admission and 28-day case fatality rate. Cerebrovasc Dis. 2007;24(6):495-9. doi: 10.1159/000110418. [PubMed: 17971627].
  • 19. Ghandehari K, Moud ZI. Incidence and etiology of ischemic stroke in Persian young adults. Acta Neurol Scand. 2006;113(2):121-4. doi: 10.1111/j.1600-0404.2005.00515.x. [PubMed: 16411973].
  • 20. Sarsarshahi A, Boostani R, Sarsarshahi S, Kiani R. Evaluation of risk factors of patients with subarachnoid hemorrhage in Motahari Hospital of Urmia University (March 2002-March 2006). Med J Mashhad Univ Med Sci. 2007;50(4):367-70.
  • 21. Talebi M, Ghertasi M, Taheraghdam A, Andalib S, Sharifipour E. A comparison of risk factors and severity of ischemic stroke in female and male genders in North-West Iran: A cross-sectional study. Iran J Neurol. 2014;13(4):215-9. [PubMed: 25632333]. [PubMed Central: PMC4300796].
  • 22. Fahimfar N, Khalili D, Mohebi R, Azizi F, Hadaegh F. Risk factors for ischemic stroke; results from 9 years of follow-up in a population based cohort of Iran. BMC Neurol. 2012;12:117. doi: 10.1186/1471-2377-12-117. [PubMed: 23031547]. [PubMed Central: PMC3517457].
  • 23. Ghandehari K, Izadi-Mood Z. Incidence and etiology of pediatric stroke in southern Khorasan. ARYA Atheroscler J. 2010;3(1):29-33.
  • 24. Sarrafzadegan N, Gharipour M, Sadeghi M, Nezafati P, Talaie M, Oveisgharan S, et al. Metabolic syndrome and the risk of ischemic stroke. J Stroke Cerebrovasc Dis. 2017;26(2):286-94. doi: 10.1016/j.jstrokecerebrovasdis.2016.09.019. [PubMed: 27769610].
  • 25. Chang YJ, Ryu SJ, Lin SK. Carotid artery stenosis in ischemic stroke patients with nonvalvular atrial fibrillation. Cerebrovasc Dis. 2002;13(1):16-20. doi: 10.1159/000047740. [PubMed: 11810005].
  • 26. Tan TY, Chang KC, Liou CW, Schminke U. Prevalence of carotid artery stenosis in Taiwanese patients with one ischemic stroke. J Clin Ultrasound. 2005;33(1):1-4. doi: 10.1002/jcu.20081. [PubMed: 15690439].
  • 27. Fernandes M, Keerthiraj B, Mahale AR, Kumar A, Dudekula A. Evaluation of carotid arteries in stroke patients using color Doppler sonography: A prospective study conducted in a tertiary care hospital in South India. Int J Appl Basic Med Res. 2016;6(1):38-44. doi: 10.4103/2229-516X.174007. [PubMed: 26958521]. [PubMed Central: PMC4765273].
  • 28. Connor MD, Walker R, Modi G, Warlow CP. Burden of stroke in black populations in sub-Saharan Africa. Lancet Neurol. 2007;6(3):269-78. doi: 10.1016/S1474-4422(07)70002-9. [PubMed: 17303533].
  • 29. Liu M, Wu B, Wang WZ, Lee LM, Zhang SH, Kong LZ. Stroke in China: Epidemiology, prevention, and management strategies. Lancet Neurol. 2007;6(5):456-64. doi: 10.1016/S1474-4422(07)70004-2. [PubMed: 17434100].
  • 30. Al-Jishi AA, Mohan PK. Profile of stroke in Bahrain. Neurosciences (Riyadh). 2000;5(1):30-4. [PubMed: 24276659].
  • 31. El Zunni S, Ahmed M, Prakash PS, Hassan KM. Stroke: Incidence and pattern in Benghazi, Libya. Ann Saudi Med. 1995;15(4):367-9. doi: 10.5144/0256-4947.1995.367. [PubMed: 17590609].
  • 32. Khosravi A, Rao C, Naghavi M, Taylor R, Jafari N, Lopez AD. Impact of misclassification on measures of cardiovascular disease mortality in the Islamic Republic of Iran: A cross-sectional study. Bull World Health Organ. 2008;86(9):688-96. doi: 10.2471/BLT.07.046532. [PubMed: 18797644]. [PubMed Central: PMC2649498].

Featured Image:

Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments